New research on bioengineering from E. Balboa and co-authors summarized

Fresh data on bioengineering are presented in the report 'Pharmacogenetic analysis in neoadjuvant chemoradiation for rectal cancer: high incidence of somatic mutations and their relation with response.' According to recent research published in the journal Pharmacogenomics, "The identification of predictive markers of response to chemoradiotherapy treatment remains a promising approach for patient management in order to obtain the best response with minor side effects. Initially, we investigated whether the analysis of several markers previously studied and others not yet evaluated could predict response to 5-fluorouracil-and capecitabine-based neoadjuvant treatment in locally...

Want to see the full article?

• Purchase this article for only $3.00